Ces radiol. 2021, 75(4):306-311 | DOI: 10.55095/CesRadiol2021/039

Diffusion-weighted imaging in the diagnosis of prostate cancerOriginal article

Pavla Hanzlíková1,2, Kateřina Ryšánková3,4, Dominik Vilímek5, Jakub Cvek6,7
1 Ústav radiodiagnostický FN, Ostrava
2 Ústav zobrazovacích metod OU, Ostrava
3 Urologická klinika FN, Ostrava
4 Katedra chirurgických oborů OU, Ostrava
5 Katedra kybernetiky a biomedicínského inženýrství VŠB-TU, Ostrava
6 Onkologická klinika FN, Ostrava
7 Klinika onkologická LF, Ostrava

The article presents the current approach to diagnosing prostate cancer using magnetic resonance imaging by diffusion-weighted DWI. DWI is one of the main pillars of the PI-RADS system for assessing the risk of prostate cancer. This sequence is an available, native and, with optimized parameter setting, minimally burdensome examination technique. Its standard and advanced settings and design have a high diagnostic yield. Performing quantification and thus a certain degree of objectification can further increase the benefit of the method. Another challenge of the technique is undoubtedly the use of other values of diffusion factor, either in very low or high values. This technique may lead to the routine using of other diffusion evaluation parameters in clinical practice. It could help assess the degree of prostate tumour aggression and estimate development of aggressiveness and risk of extracapsular extension.

Keywords: magnetic resonance, prostate cancer, DWI, ADC, IVIM, kurtosis
Grants and funding:

Implementace pokročilých metod difuze pro použití ve Fakultní nemocnici Ostrava je podpořeno projektem MZ ČR - RVO (RVO-FNOs/2020 - FN Ostrava, IČ 00843989), zahájeno v roce 2020.

Accepted: December 15, 2021; Published: December 1, 2021  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Hanzlíková P, Ryšánková K, Vilímek D, Cvek J. Diffusion-weighted imaging in the diagnosis of prostate cancer. Ces radiol. 2021;75(4):306-311. doi: 10.55095/CesRadiol2021/039.
Download citation

References

  1. Miyahira AK, Sharp A, Ellis L, Jones J, Kaochar S, Larman HB, Quigley DA, Ye H, Simons JW, Pienta KJ, Soule HR. Prostate cancer research: The next generation; report from the 2019 Coffey-Holden Prostate Cancer Academy Meeting. Prostate 2020; 80(2): 113-132. doi: 10.1002/pros.23934 Go to original source... Go to PubMed...
  2. Ritch C, Cookson M. Recent trends in the management of advanced prostate cancer. F1000Res 2018; 7. doi: 10.12688/f1000research.15382.1 Go to original source... Go to PubMed...
  3. Schymura MJ, Sun L, Percy-Laurry A. Prostate cancer collaborative stage data items - their definitions, quality, usage, and clinical implications: a review of SEER data for 2004-2010. Cancer 2014; 120(Suppl 23): 3758-3770. doi: 10.1002/cncr.29052 Go to original source... Go to PubMed...
  4. Hectors SJ, Wagner M, Corcuera-Solano I, Kang M, Stemmer A, Boss MA, Taouli B. Comparison Between 3-Scan Trace and Diagonal Body Diffusion-Weighted Imaging Acquisitions: A Phantom and Volunteer Study. Tomography 2016; 2(4): 411-420. doi: 10.18383/j.tom.2016.00229 Go to original source... Go to PubMed...
  5. Corcuera-Solano I, Wagner M, Hectors S, Lewis S, Titelbaum N, Stemmer A, Rastinehad A, Tewari A, Taouli B. DWI of the prostate: Comparison of a faster diagonal acquisition to standard three-scan trace acquisition. J Magn Reson Imaging 2017; 46(6): 1767-1775. doi: 10.1002/jmri.25705 Go to original source... Go to PubMed...
  6. le Bihan D, Breton E, Lallemand D, Grenier P, Cabanis E, Laval-Jeantet M. MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology 1986; 161(2): 401-407. doi: 10.1148/radiology.161.2.3763909 Go to original source... Go to PubMed...
  7. Charles-Edwards EM, deSouza NM. Diffusion-weighted magnetic resonance imaging and its application to cancer. Cancer Imaging 2006; 6: 135-143. doi: 10.1102/1470-7330.2006.0021 Go to original source... Go to PubMed...
  8. Kingsley PB, Monahan WG. Selection of the optimum b factor for diffusion-weighted magnetic resonance imaging assessment of ischemic stroke. Magn Reson Med 2004; 51(5): 996-1001. doi: 10.1002/mrm.20059 Go to original source... Go to PubMed...
  9. Jendoubi S, Wagner M, Montagne S, Ezziane M, Mespoulet J, Comperat E, Estellat C, Baptiste A, Renard-Penna R. MRI for prostate cancer: can computed high b-value DWI replace native acquisitions? Eur Radiol 2019; 29(10): 5197-5204. doi: 10.1007/s00330-019-06085-z Go to original source... Go to PubMed...
  10. Porter DA, Heidemann RM. High resolution diffusion-weighted imaging using readout-segmented echo-planar imaging, parallel imaging and a two-dimensional navigator-based reacquisition. Magn Reson Med 2009; 62(2): 468-475. doi: 10.1002/mrm.22024 Go to original source... Go to PubMed...
  11. Hoge WS, Brooks DH. On the complimentarity of SENSE and GRAPPA in parallel MR imaging. Conf Proc IEEE Eng Med Biol Soc 2006; 2006: 755-758. doi: 10.1109/IEMBS.2006.259697 Go to original source... Go to PubMed...
  12. Breuer FA, Blaimer M, Heidemann RM, Mueller MF, Griswold MA, Jakob PM. Controlled aliasing in parallel imaging results in higher acceleration (CAIPIRINHA) for multi-slice imaging. Magn Reson Med 2005; 53(3): 684-691. doi: 10.1002/mrm.20401 Go to original source... Go to PubMed...
  13. Turkbey B, Rosenkrantz AB, Haider MA, Padhani AR, Villeirs G, Macura KJ, Tempany CM, Choyke PL, Cornud F, Margolis DJ, Thoeny HC, Verma S, Barentsz J, Weinreb JC. Prostate Imaging Reporting and Data System Version 2.1: 2019 Update of Prostate Imaging Reporting and Data System Version 2. Eur Urol 2019; 76(3): 340-351. doi: 10.1016/j.eururo.2019.02.033 Go to original source... Go to PubMed...
  14. Shaish H, Kang SK, Rosenkrantz AB. The utility of quantitative ADC values for differentiating high-risk from low-risk prostate cancer: a systematic review and meta-analysis. Abdom Radiol (NY) 2017; 42(1): 260-270. doi: 10.1007/s00261-016-0848-y Go to original source... Go to PubMed...
  15. Rosenkrantz AB, Parikh N, Kierans AS, Kong MX, Babb JS, Taneja SS, Ream JM. Prostate Cancer Detection Using Computed Very High b-value Diffusion-weighted Imaging: How High Should We Go? Acad Radiol 2016; 23(6): 704-711. doi: 10.1016/j.acra.2016.02.003 Go to original source... Go to PubMed...
  16. Giganti F, Coppola A, Ambrosi A, Ravelli S, Esposito A, Freschi M, Briganti A, Scattoni V, Salonia A, Gallina A, Dehò F, Cardone G, Balconi G, Gaboardi F, Montorsi F, Maschio AD, de Cobelli F. Apparent diffusion coefficient in the evaluation of side-specific extracapsular extension in prostate cancer: Development and external validation of a nomogram of clinical use. Urol Oncol 2016; 34(7). doi: 10.1016/j.urolonc.2016.02.015 Go to original source... Go to PubMed...
  17. Ren J, Huan Y, Wang H, Ge Y, Chang Y, Yin H, Sun L. Seminal vesicle invasion in prostate cancer: prediction with combined T2-weighted and diffusion-weighted MR imaging. Eur Radiol 2009; 19(10): 2481-2486. doi: 10.1007/s00330-009-1428-0 Go to original source... Go to PubMed...
  18. Maurer MH, Heverhagen JT. Diffusion weighted imaging of the prostate-principles, application, and advances. Transl Androl Urol 2017; 6(3): 490-498. doi: 10.21037/tau.2017.05.06 Go to original source... Go to PubMed...
  19. Lebovici A, Sfrangeu SA, Feier D, Caraiani C, Lucan C, Suciu M, Elec F, Iacob G, Buruian M. Evaluation of the normal-to-diseased apparent diffusion coefficient ratio as an indicator of prostate cancer aggressiveness. BMC Med Imaging 2014; 14: 15. doi: 10.1186/1471-2342-14-15 Go to original source... Go to PubMed...
  20. Vargas HA, Akin O, Franiel T, Mazaheri Y, Zheng J, Moskowitz C, Udo K, Eastham J, Hricak H. Diffusion-weighted endorectal MR imaging at 3 T for prostate cancer: tumor detection and assessment of aggressiveness. Radiology 2011; 259(3): 775-784. doi: 10.1148/radiol.11102066 Go to original source... Go to PubMed...
  21. Giganti F, Pecoraro M, Fierro D, Campa R, Del Giudice F, Punwani S, Kirkham A, Allen C, Emberton M, Catalano C, Moore CM, Panebianco V. DWI and PRECISE criteria in men on active surveillance for prostate cancer: A multicentre preliminary experience of different ADC calculations. Magn Reson Imaging 2020; 67: 50-58. doi: 10.1016/j.mri.2019.12.007 Go to original source... Go to PubMed...
  22. Cha D, Kim CK, Park SY, Park JJ, Park BK. Evaluation of suspected soft tissue lesion in the prostate bed after radical prostatectomy using 3T multiparametric magnetic resonance imaging. Magn Reson Imaging 2015; 33(4): 407-412. doi: 10.1016/j.mri.2014.12.003 Go to original source... Go to PubMed...
  23. le Bihan D. Intravoxel incoherent motion perfusion MR imaging: a wake-up call. Radiology 2008; 249(3): 748-752. doi: 10.1148/radiol.2493081301 Go to original source... Go to PubMed...
  24. Szubert-Franczak AE, Naduk-Ostrowska M, Pasicz K, Podgórska J, Skrzyński W, Cieszanowski A. Intravoxel incoherent motion magnetic resonance imaging: basic principles and clinical applications. Pol J Radiol 2020; 85: e624-e635. doi: 10.5114/pjr.2020.101476 Go to original source... Go to PubMed...
  25. Yao W, Liu J, Zheng J, Lu P, Zou S, Xu Y. Study on diagnostic value of quantitative parameters of intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI) in prostate cancer. Am J Transl Res 2021; 13(4): 3696-3702.
  26. Liu G, Lu Y, Dai Y, Xue K, Yi Y, Xu J, Wu D, Wu G. Comparison of mono-exponential, bi-exponential, kurtosis, and fractional-order calculus models of diffusion-weighted imaging in characterizing prostate lesions in transition zone. Abdom Radiol (NY) 2021. doi: 10.1007/s00261-020-02903-x Go to original source... Go to PubMed...
  27. Jensen JH, Helpern JA, Ramani A, Lu H, Kaczynski K. Diffusional kurtosis imaging: the quantification of non-gaussian water diffusion by means of magnetic resonance imaging. Magn Reson Med 2005; 53(6): 1432-1440. doi: 10.1002/mrm.20508 Go to original source... Go to PubMed...
  28. Rosenkrantz AB, Padhani AR, Chenevert TL, Koh DM, De Keyzer F, Taouli B, le Bihan D. Body diffusion kurtosis imaging: Basic principles, applications, and considerations for clinical practice. J Magn Reson Imaging 2015; 42(5): 1190-1202. doi: 10.1002/jmri.24985 Go to original source... Go to PubMed...
  29. Valerio M, Zini C, Fierro D, Giura F, Colarieti A, Giuliani A, Laghi A, Catalano C, Panebianco V. 3T multiparametric MRI of the prostate: Does intravoxel incoherent motion diffusion imaging have a role in the detection and stratification of prostate cancer in the peripheral zone? Eur J Radiol 2016; 85(4): 790-794. doi: 10.1016/j.ejrad.2016.01.006 Go to original source... Go to PubMed...
  30. Si Y, Liu RB. Diagnostic Performance of Monoexponential DWI Versus Diffusion Kurtosis Imaging in Prostate Cancer: A Systematic Review and Meta-Analysis. AJR Am J Roentgenol 2018; 211(2): 358-368. doi: 10.2214/AJR.17.18934 Go to original source... Go to PubMed...

This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International License (CC BY 4.0), which permits use, distribution, and reproduction in any medium, provided the original publication is properly cited. No use, distribution or reproduction is permitted which does not comply with these terms.